ICON's top-line growth has stalled at just 2.3% year-over-year, while gross margins have collapsed by over 1,000 basis points from 29.6% in early 2024 to 18.8% in Q2 2026, suggesting severe cost pressures from the PRA integration and labor inflation that are e...
Price trend, volume and key moving averages
Start with the evidence for owning the stock and the risks that can break the thesis.
Revenue growth has decelerated to just 2.3% year-over-year in Q2 2026, while gross margins have plummeted to 18.8%, indicating severe cost pressure from labor and project mix that has eliminated prior operating leverage.
Book-to-bill ratio recovers to 1.2x+ in 2026-2027, driving backlog and revenue re-acceleration toward 5% organic growth.
Combined with buybacks, margin improvement, and intangible amortization burn-down, the company projects $15+ adj. EPS by FY 2028.
The bullish case supports a re-rating to 12-15x forward earnings, implying a stock price range of $180-$225.
Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Jul 29, 2026 | $2.56+0.4% vs $2.55 | $2.1B+3.0% vs $2.0B |
Q3 2026 Jun 23, 2026 | $2.50+1.6% vs $2.46 | $2.0B+1.8% vs $2.0B |
Q2 2026 May 28, 2026 | $2.52-14.6% vs $2.95 | $2.1B+6.6% vs $2.0B |
Q2 2026 May 27, 2026 | $2.52-19.5% vs $3.13 | $2.1B+6.6% vs $2.0B |
WINTON GROUP Ltd cut its stake in Icon Plc (NASDAQ: ICLR) by 94.1% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,800 shares of the medical research company's stock after selling 28,754 shares during the period. WINTON
Icon PLC (ICLR) reported earnings 30 days ago. What's next for the stock?
On August 19, 2026, Icon PLC (ICLR) shares rose 3.2% today, closing at $172.49, which is within its 52-week range of $66.57 to $203.91. This recent uptick in sh
On August 17, 2026, Icon PLC (ICLR) shares rose 3.9%, bringing the current price to $169.45. This price is situated within a 52-week range of $66.57 to $203.91,
Benchmark ICLR against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for ICON Public Limited Company (ICLR)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $163.90 | $12.55B | 56.52 | -0.37% | 2.78% | 2.45% | — | |
| $277.33 | $13.36B | -95.30 | -0.85% | -5.96% | -7.63% | — | |
| $267.86 | $44.09B | 34.17 | 5.87% | 8.1% | 21.51% | — | |
| $617.15 | $17.23B | 40.39 | 19.97% | 17.67% | 110.15% | — | |
| $25.00 | $1.29B | 25.25 | -2.67% | 6.04% | 4.95% | — | |
| $303.98 | $24.93B | 29.06 | 7.25% | 6.99% | 11.55% | — |
ICON Public Limited Company (ICLR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when ICLR posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
ICON Public Limited Company (ICLR) stock FAQ — growth, dividends, profitability & financials explained
ICON Public Limited Company (ICLR) reported $8.25B in revenue for fiscal year 2025. This represents a 14690% increase from $55.8M in 1998.
ICON Public Limited Company (ICLR) saw revenue decline by 0.4% over the past year.
Yes, ICON Public Limited Company (ICLR) is profitable, generating $328.9M in net income for fiscal year 2025 (2.8% net margin).
ICON Public Limited Company (ICLR) has a return on equity (ROE) of 2.5%. This is below average, suggesting room for improvement.
ICON Public Limited Company (ICLR) generated $1.35B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
